Atterocor Lands $16M Series A Round For Cancer Therapy
11:17 EDT 7 Aug 2012 | Xconomy
Ann Arbor, MI-based Atterocor announced Friday that it has raised $16 million in a Series A round led by Frazier, based in Seattle and Menlo Park, CA, and 5am Ventures, based in Waltham, MA and Menlo Park. The funding will go toward developing the..
Original Article: Atterocor Lands $16M Series A Round For Cancer Therapy
More From BioPortfolio on "Atterocor Lands $16M Series A Round For Cancer Therapy"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
